semaglutide news october 2025 Drugmakers battle pharmacies over compounded Ozempic and Zepbound : Shots semaglutide news october 2025 Impact

It may be appropriate for adults with type 2 diabetes who need improved blood-sugar control and, in certain cases, cardiovascular or kidney-risk reduction

If you do decide to stop using semaglutide altogether, stick to eating smaller portions to help maintain your results

Chickpeas also elicit a strong GLP-1 response from the body

Your data is encrypted and stored securely, and we do not share or sell your information to third parties

Heres another key difference: Zepbound is available now, while Retatrutide is not yet FDA-approved and wont be on the market until it passes Phase 3 trials and gets regulatory approval